PharmaEssentia (6446.TW) Stock Price

PharmaEssentia Price

CLOSED
1,260.00
​
Market closed

The consensus 12-month price target for PharmaEssentia is 632.40 TWD, about 49.8% below where the stock trades today. Of 15 analysts, 12 rate the stock a buy — an overall Buy consensus.

PharmaEssentia stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

PharmaEssentia business model & stock analysis

PharmaEssentia Corp develops and sells drugs for hematology, infectious diseases, dermatology, and neurology. Its products include KX01, P1101, Polycythemia Vera (PV), PEG-GCSF, and PEG-EPO, targeting conditions like MPN, hepatitis C, psoriasis, and multiple sclerosis. The company sells these drugs domestically in Taipei and internationally to overseas markets. The firm generates revenue through the sale of its pharmaceutical products to healthcare providers and distributors. Its research and development focus on new drugs for specific medical conditions, with products distributed across multiple therapeutic areas. PharmaEssentia Corp's market segments include hematology, infectious disease, dermatology, and neurology, serving both local and global healthcare systems. PharmaEssentia Corp's business model centers on developing and commercializing prescription drugs for specialized medical treatments. The company's product portfolio targets high-demand therapeutic areas, with sales driven by both domestic and international distribution channels. Its revenue streams are derived from the ongoing sale of established products and the pipeline of new drug developments.

Frequently asked questions about PharmaEssentia

Analysts currently set an average price target of 748.68 TWD for the PharmaEssentia stock (median: 632.40 TWD), implying -40.6 % versus the latest price. The consensus is based on 15 analyst ratings.

15 analysts currently rate the PharmaEssentia stock: 12 recommend buying, 3 holding and 0 selling.

Converted at the current exchange rate, the PharmaEssentia share trades at 34.85 EUR (1,260.00 TWD).

The revenue cannot currently be calculated for PharmaEssentia.

The profit cannot currently be calculated for PharmaEssentia.

The P/E ratio cannot be calculated for PharmaEssentia at the moment.

The P/S cannot be calculated for PharmaEssentia currently.

The Eulerpool Quality Score for PharmaEssentia is 2/10.

The ISIN of PharmaEssentia is TW0006446008. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of PharmaEssentia is 6446.TW. The ticker symbol is used to trade PharmaEssentia shares on the stock exchange.

Fair ValueTerminal
1,184.40 TWD
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Biotechnology
Number of shares
Employees
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Country
Taiwan
Currency
TWD
Initial public offering
Mar 11, 2014
ISIN
TW0006446008
Cusip
Y6S28C101
Market capitalization
478.33 B TWDMega Cap
52-Week Range
PEG
—
P/E ratio
P/Ee
—
P/S
P/Se
—
EV/EBIT
—
P/B Ratio
—
ROE (Return on Equity)
—
ROA (Return on Assets)
—
ROCE (Return on Capital Employed)
—
ROIC (Return on Invested Capital)
—
Last updated Nov 19, 2026, 8:43 PM

PharmaEssentia Peer Group

PharmaEssentia FIGI

6446:TT (Taipei Stock Exchange) · BBG0063GF2066446TWD:EO · BBG01BTX66826446TWD:X2 · BBG01BTX66916446TWD:XH · BBG01BTX66C76446TWD:XF · BBG01BTX66F46446TWD:XE · BBG01BTX66H26446TWD:XJ · BBG01BTX66J06446TWD:XL · BBG01BTX66K86446TWD:XG · BBG01BTX66L76446TWD:XO · BBG01BTX66M66446TWD:XA · BBG01BTX66R16446TWD:E1 · BBG01BTX66S0

All fundamentals and in-depth analysis of PharmaEssentia

Our stock analysis for PharmaEssentia stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of PharmaEssentia. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.